A J Ten Tije
Overview
Explore the profile of A J Ten Tije including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Goey K, Elias S, van Tinteren H, Lacle M, Willems S, Offerhaus G, et al.
Ann Oncol
. 2017 Sep;
28(9):2128-2134.
PMID: 28911067
Background: The phase 3 CAIRO3 study showed that capecitabine plus bevacizumab (CAP-B) maintenance treatment after six cycles capecitabine, oxaliplatin, and bevacizumab (CAPOX-B) in metastatic colorectal cancer (mCRC) patients is effective,...
12.
Blox W, Gobardhan P, Rozema T, Koornstra R, de Groot J, Ten Tije A
Ned Tijdschr Geneeskd
. 2017 May;
161:D855.
PMID: 28537537
Histopathological examination of possible metastasis; indispensable or diagnostic excess?
13.
Kwakman J, Simkens L, van Rooijen J, van de Wouw A, Ten Tije A, Creemers G, et al.
Ann Oncol
. 2017 Apr;
28(6):1288-1293.
PMID: 28383633
Background: Hand-foot syndrome (HFS) is a common side-effect of capecitabine. S-1 is an oral fluoropyrimidine with comparable efficacy to capecitabine in gastrointestinal cancers but associated with a lower incidence of...
14.
Franken M, van Rooijen E, May A, Koffijberg H, van Tinteren H, Mol L, et al.
Eur J Cancer
. 2017 Feb;
75:204-212.
PMID: 28237866
Aim: Capecitabine and bevacizumab (CAP-B) maintenance therapy has shown to be more effective compared with observation in metastatic colorectal cancer patients achieving stable disease or better after six cycles of...
15.
Leeneman B, Franken M, Blommestein H, van Gils C, van der Meijde E, Wouters M, et al.
Value Health
. 2016 May;
17(7):A618-9.
PMID: 27202168
No abstract available.
16.
Devilee R, Simkens G, van Oudheusden T, Rutten H, Creemers G, Ten Tije A, et al.
Ann Surg Oncol
. 2016 Apr;
23(9):2841-8.
PMID: 27044447
Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) can result in long-term survival for selected patients with colorectal peritoneal metastases (PM). Most patients are additionally treated with systemic...
17.
Baas J, Krens L, Ten Tije A, Erdkamp F, van Wezel T, Morreau H, et al.
Invest New Drugs
. 2015 Sep;
33(6):1242-7.
PMID: 26386973
Introduction: Cetuximab is registered for use in colorectal cancer (CRC) patients with RAS wild-type tumours only. Simvastatin blocks the mevalonate pathway and thereby interferes with the post-translational modification (prenylation) of...
18.
Lam S, de Groot S, Honkoop A, Jager A, Ten Tije A, Bos M, et al.
Eur J Cancer
. 2014 Dec;
50(18):3077-88.
PMID: 25459393
Background: The addition of bevacizumab to paclitaxel or capecitabine has demonstrated improved progression-free survival (PFS) and objective response rate (ORR) as compared with chemotherapy alone in patients with HER2-negative locally...
19.
[Treatment of colorectal liver metastasis at a regional hospital versus a university medical centre]
de Leur K, Huisman F, Gobardhan P, Kint P, Wijsman J, Ten Tije A, et al.
Ned Tijdschr Geneeskd
. 2013 Aug;
157(34):A6417.
PMID: 23965247
Objective: To evaluate the results of this type of liver surgery performed at a specialised regional hospital in comparison with the operation performed at a university medical centre (UMC). Design:...
20.
Gobardhan P, de Wall L, van der Laan L, Ten Tije A, van der Meer D, Tetteroo E, et al.
Ann Oncol
. 2012 Nov;
24(3):668-73.
PMID: 23139261
Background: Neoadjuvant chemotherapy (NAC) is increasingly used in the framework of breast-conserving therapy (BCT). Localization of the initial tumor is essential to guide surgical resection after NAC. This study describes...